|
TMF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63236091310637E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.59181606468928E-12 |
| Normal-vs-Stage2 |
2.32129999666597E-08 |
| Normal-vs-Stage3 |
2.96040969516298E-12 |
| Normal-vs-Stage4 |
3.31700222844233E-11 |
| Stage1-vs-Stage2 |
4.167600E-01 |
| Stage1-vs-Stage3 |
1.280820E-01 |
| Stage1-vs-Stage4 |
7.340500E-02 |
| Stage2-vs-Stage3 |
7.769400E-01 |
| Stage2-vs-Stage4 |
4.367800E-01 |
| Stage3-vs-Stage4 |
5.536600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.14113188185183E-14 |
| Normal-vs-AfricanAmerican |
1.519150E-03 |
| Normal-vs-Asian |
7.51450002223208E-09 |
| Caucasian-vs-AfricanAmerican |
1.549800E-01 |
| Caucasian-vs-Asian |
6.802400E-01 |
| AfricanAmerican-vs-Asian |
1.421850E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.91748872125208E-14 |
| Normal-vs-Female |
2.40540920515286E-12 |
| Male-vs-Female |
1.717630E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.16400000749195E-09 |
| Normal-vs-Age(41-60Yrs) |
3.00648395068492E-13 |
| Normal-vs-Age(61-80Yrs) |
4.53925785848242E-12 |
| Normal-vs-Age(81-100Yrs) |
3.418900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.455900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.368400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.476800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.483600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.321800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.944200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.660100E-02 |
| Classical-VS-Follicular |
6.264000E-02 |
| Classical-VS-Other |
2.675600E-01 |
| Classical-VS-Normal |
1.53900225896564E-11 |
| Tall-VS-Follicular |
5.882200E-01 |
| Tall-VS-Other |
8.206800E-01 |
| Tall-VS-Normal |
2.27079999248758E-09 |
| Follicular-VS-Other |
6.628600E-01 |
| Follicular-VS-Normal |
1.99550043156194E-10 |
| Other-VS-Normal |
9.754100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.48290318597356E-14 |
| Normal-vs-N1 |
1.04819997126526E-09 |
| N0-vs-N1 |
7.261400E-01 |
|
|
